2024 Q3 Form 10-Q Financial Statement

#000117891324002522 Filed on August 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $42.00K $57.00K
YoY Change
Cost Of Revenue $42.00K $48.00K
YoY Change
Gross Profit $0.00 $9.000K
YoY Change
Gross Profit Margin 0.0% 15.79%
Selling, General & Admin $1.544M $1.088M
YoY Change 49.9% -4.14%
% of Gross Profit 12088.89%
Research & Development $1.477M $1.086M
YoY Change 7.81% -10.17%
% of Gross Profit 12066.67%
Depreciation & Amortization $11.00K $11.00K
YoY Change 10.0% -26.67%
% of Gross Profit 122.22%
Operating Expenses $3.021M $2.174M
YoY Change 26.61% -6.7%
Operating Profit -$3.021M -$2.165M
YoY Change 26.61% -7.08%
Interest Expense $0.00 $20.00K
YoY Change -100.0% 300.0%
% of Operating Profit
Other Income/Expense, Net $0.00 $20.00K
YoY Change -100.0% 300.0%
Pretax Income -$3.021M -$2.145M
YoY Change 28.55% -7.74%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$3.021M -$2.145M
YoY Change 26.99% -7.74%
Net Earnings / Revenue -7192.86% -3763.16%
Basic Earnings Per Share $0.08 $0.06
Diluted Earnings Per Share $0.08 $0.06
COMMON SHARES
Basic Shares Outstanding 36.32M shares 35.79M shares
Diluted Shares Outstanding 37.64M shares 37.09M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.915M $9.056M
YoY Change -8.89% -0.86%
Cash & Equivalents $6.915M $9.056M
Short-Term Investments
Other Short-Term Assets $89.00K $67.00K
YoY Change -66.16% -81.07%
Inventory
Prepaid Expenses $147.0K $268.0K
Receivables $42.00K $57.00K
Other Receivables $69.00K $69.00K
Total Short-Term Assets $7.340M $9.595M
YoY Change -8.43% -2.23%
LONG-TERM ASSETS
Property, Plant & Equipment $65.00K $76.00K
YoY Change -39.81% -37.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $20.00K $20.00K
YoY Change 0.0% -59.18%
Total Long-Term Assets $401.0K $440.0K
YoY Change -26.96% -30.27%
TOTAL ASSETS
Total Short-Term Assets $7.340M $9.595M
Total Long-Term Assets $401.0K $440.0K
Total Assets $7.741M $10.04M
YoY Change -9.62% -3.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $184.0K $69.00K
YoY Change -67.38% -71.25%
Accrued Expenses $927.0K $1.225M
YoY Change -36.51% -24.62%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.111M $1.294M
YoY Change -45.19% -30.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $178.0K $209.0K
YoY Change -40.67% -39.94%
Total Long-Term Liabilities $178.0K $209.0K
YoY Change -41.06% -39.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.111M $1.294M
Total Long-Term Liabilities $178.0K $209.0K
Total Liabilities $1.289M $1.503M
YoY Change -44.65% -32.08%
SHAREHOLDERS EQUITY
Retained Earnings -$111.6M -$108.5M
YoY Change 8.99% 8.5%
Common Stock $118.0M $117.0M
YoY Change 8.65% 8.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.452M $8.532M
YoY Change
Total Liabilities & Shareholders Equity $7.741M $10.04M
YoY Change -9.62% -3.93%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$3.021M -$2.145M
YoY Change 26.99% -7.74%
Depreciation, Depletion And Amortization $11.00K $11.00K
YoY Change 10.0% -26.67%
Cash From Operating Activities -$2.154M -$1.335M
YoY Change 41.71% -14.37%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.00K 1.216M
YoY Change 24220.0%
NET CHANGE
Cash From Operating Activities -2.154M -1.335M
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 13.00K 1.216M
Net Change In Cash -2.141M -119.0K
YoY Change 40.86% -92.35%
FREE CASH FLOW
Cash From Operating Activities -$2.154M -$1.335M
Capital Expenditures $0.00 $0.00
Free Cash Flow -$2.154M -$1.335M
YoY Change 41.71% -14.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Assets
Assets
10035000 usd
CY2024Q2 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
30000 usd
CY2023Q4 us-gaap Postemployment Benefits Liability Noncurrent
PostemploymentBenefitsLiabilityNoncurrent
32000 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
209000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104386000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11765000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4162000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-14000 usd
CY2024Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
166000 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
159000 usd
CY2024Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
260000 usd
CY2023Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
215000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
644000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
500000 usd
CY2024Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1070000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
874000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9056000 usd
CY2023Q4 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
6000 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
508000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
83000 usd
CY2024Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1070000 usd
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
874000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1091000 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
117038000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
114730000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
41000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
41000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
8532000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4515000 usd
us-gaap Depreciation
Depreciation
24000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1062000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
988000 usd
entx Finance Expenses Net
FinanceExpensesNet
-14000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
356000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3197000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3168000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1951000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9056000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
11257000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
100000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1379000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
10386000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10035000 usd
entx Finance Expenses Net
FinanceExpensesNet
-6000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-217000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
232000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
196000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
252000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
9595000 usd
CY2023Q4 us-gaap Assets
Assets
11765000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
69000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36913725 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28811162 shares
us-gaap Depreciation
Depreciation
29000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3175000 usd
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
66000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
179000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
256000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-108548000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4162000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4515000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36913725 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28811162 shares
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9201000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9135000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
78000 usd
entx Right Of Use Assets Obtained In Exchange For New Operating Lease Liabilities
RightOfUseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities
33000 usd
entx Right Of Use Assets Obtained In Exchange For New Operating Lease Liabilities
RightOfUseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities
449000 usd
dei Entity Small Business
EntitySmallBusiness
true
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
344000 usd
CY2024Q2 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
6000 usd
CY2024Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
440000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2140000 usd
us-gaap Other Nonrecurring Income
OtherNonrecurringIncome
27000 usd
us-gaap Operating Expenses
OperatingExpenses
4236000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
10386000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4162000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1062000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
8532000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11754000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4515000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
988000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
8232000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
223000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1246000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9134000 usd
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
268000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
34000 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
67000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
69000 usd
CY2024Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
14000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
1503000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
482000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
238000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
388000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
288000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1821000 usd
us-gaap Other Nonrecurring Income
OtherNonrecurringIncome
0 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
65000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
27000 usd
entx Exercise Of Warrants Value
ExerciseOfWarrantsValue
90000 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
57000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11085000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9134000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9201000 usd
entx Interest Received
InterestReceived
66000 usd
entx Interest Received
InterestReceived
0 usd
CY2024Q2 entx Advance Income Tax
AdvanceIncomeTax
69000 usd
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
9112002
dei Trading Symbol
TradingSymbol
ENTX
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36324579 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11019000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
57000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
14000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
155000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
134000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1294000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
us-gaap Revenues
Revenues
57000 usd
us-gaap Revenues
Revenues
0 usd
CY2024Q2 us-gaap Revenues
Revenues
57000 usd
CY2023Q2 us-gaap Revenues
Revenues
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
48000 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
48000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Gross Profit
GrossProfit
9000 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
9000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
0 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1086000 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1209000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2415000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2429000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1088000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1135000 usd
CY2024Q2 us-gaap Other Nonrecurring Income
OtherNonrecurringIncome
0 usd
CY2023Q2 us-gaap Other Nonrecurring Income
OtherNonrecurringIncome
14000 usd
us-gaap Operating Expenses
OperatingExpenses
4542000 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
2174000 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
2330000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4227000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4542000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2165000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2330000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
20000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2145000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2325000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37090160 shares
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37090160 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28812375 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28812375 shares
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
555000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
601000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
8863000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2145000 usd
CY2024Q2 entx Exercise Of Warrants Value
ExerciseOfWarrantsValue
60000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
555000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
601000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
0 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
598000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
8532000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
5000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
10080000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2325000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
5000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
472000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
8232000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
601000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
555000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
90000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12376000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q4 entx Advance Income Tax
AdvanceIncomeTax
69000 usd
CY2024Q2 entx Restricted Deposits
RestrictedDeposits
78000 usd
CY2023Q4 entx Restricted Deposits
RestrictedDeposits
66000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
482000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
238000 usd
us-gaap Revenues
Revenues
57000 usd
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001178913-24-002522-index-headers.html Edgar Link pending
0001178913-24-002522-index.html Edgar Link pending
0001178913-24-002522.txt Edgar Link pending
0001178913-24-002522-xbrl.zip Edgar Link pending
entx-20240630.xsd Edgar Link pending
exhibit_31-1.htm Edgar Link pending
exhibit_31-2.htm Edgar Link pending
exhibit_32-1.htm Edgar Link pending
entx-20240630_cal.xml Edgar Link unprocessable
entx-20240630_def.xml Edgar Link unprocessable
entx-20240630_pre.xml Edgar Link unprocessable
entx-20240630_lab.xml Edgar Link unprocessable
exhibit_32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zk2431762.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
zk2431762_htm.xml Edgar Link completed